Volume 29, Issue 3 (October 2022)                   J Birjand Univ Med Sci. 2022, 29(3): 275-284 | Back to browse issues page

Research code: 456349
Ethics code: IR. BUMS. REC. 1399.527


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zare-Bidaki M, Ghasemi F, Allahyari E, Ashrafipour M, Mohammadparast Tabas P, Nikoomanesh F. Investigated inhibitory effect of aqueous extract of pistachio leaf (Pistacia atlantica) on the isolates of pathogenic Escherichia coli and Candida albicans from urinary and vaginal samples. Journals of Birjand University of Medical Sciences 2022; 29 (3) :275-284
URL: http://journal.bums.ac.ir/article-1-3209-en.html
1- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2- Student Research Committee, Birjand University of Medical University, Birjand, Iran
3- Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
4- Department of Parasitology and Mycology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashahad, Iran
5- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran , g.nikoomanesh@yahoo.com
Abstract:   (956 Views)
Background and Aims: Pistacia atlantica is one of the medicinal plants native to Iran and known for its antimicrobial properties. Therefore, the present study aimed to investigate the antibacterial and antifungal effects of the aqueous extract of P. atlantica leaves on clinical isolates of Escherichia coli and Candida albicans in vivo.
Materials and Methods: In this descriptive-cross-sectional study, the minimum inhibitory concentration (MIC) and minimum bactericidal/ fungicidal concentration (MBC/MFC) of aqueous extract of pistachio leaf were determined on 60 isolates of E. coli and 60 isolates of C. albicans, according to CLSI protocol at concentrations of 0.125-100 mg/ml. The obtained results were analyzed using R software at a significance level of 0.05.
Results: The mean minimum inhibitory concentrations of coriander extract for E. coli and C. albicans clinical isolates were obtained at 45.3±1.0 and 43.7±1.1 mg/ml, respectively. The comparison of the minimum concentration of growth inhibitor and lethality of clinical isolates with standard E. coli strain was not significantly different (P=0.65); nonetheless, the standard strains of C. albicans were significantly different from the clinical isolates of this fungus (P<0.001).
Conclusion: As evidenced by the results of the present study, the aqueous extract of P. atlantica leaves has inhibitory effects on the clinical isolates of E. coli and C. albicans. Therefore, it is possible to use the aqueous extract of this plant in isolation or in combination with other drugs to treat urinary tract and vaginal infections.
Full-Text [PDF 625 kb]   (259 Downloads)    
Type of Study: Original Article | Subject: Mycology
Received: 2022/08/24 | Accepted: 2022/12/26 | ePublished: 2022/12/6

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb